NewAmsterdam Pharma Company NV (NASDAQ: NAMS) Bullish Outlook Still Prevails With Short Term Targets At $44.5
NewAmsterdam Pharma Company NV (NASDAQ:NAMS) does about 922.91K shares in volume on a normal day but saw 928397 shares change hands in the recent trading day. The company now has a market cap of 2.08B USD. Its current market price is $18.49, marking a decrease of -6.38% compared to the previous close of $19.75. The […]
Estimating Price Trends For NewAmsterdam Pharma Company NV (NASDAQ: NAMS)
NewAmsterdam Pharma Company NV (NASDAQ:NAMS) does about 923.99K shares in volume on a normal day but saw 1539396 shares change hands in the recent trading day. The company now has a market cap of 2.45B USD. Its current market price is $21.84, marking an increase of 8.33% compared to the previous close of $20.16. The […]
NewAmsterdam Pharma Company NV (NASDAQ: NAMS) Now -28.95% Off Its High ($27.29), Does Analysts See Headwinds And Risks?
NewAmsterdam Pharma Company NV (NASDAQ:NAMS) currently has a daily average trading volume of 967.44K but it saw 1306329 shares traded in last market. With a market cap of 2.18B USD, the company’s current market price of $19.39 came rising about 3.75 while comparing to the previous closing price of $18.69. In past 52 weeks, the […]
NewAmsterdam Pharma Company NV (NASDAQ: NAMS): Think Like A Lender, Not An Investor
NewAmsterdam Pharma Company NV (NASDAQ:NAMS) currently has a daily average trading volume of 1.03M but it saw 910139 shares traded in last market. With a market cap of 2.11B USD, the company’s current market price of $18.75 remained unchanged while comparing to the previous closing price of $18.75. In past 52 weeks, the stock remained […]